Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
NCT06362590
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Interventions
DRUG:
ladiratuzumab vedotin
Sponsor
Seagen Inc.